
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-50 of 263.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2011	Excellence in rheumatology istanbul, Turkey 17-19 february 2011.	Kitas, G.D.; Tsokos, G.C.; Riel, P.L. van
2011	Ups and downs in the treatment strategies of rheumatoid arthritis	Schipper, L.G.; van Riel, P.L.
2011	Rheumatoid arthritis: understanding joint damage and physical disability in RA	Punder, Y.M. de; van Riel, P.L.
2011	POEET-studie: horizon bij behandeling met biologicals bepalen.	Jansen, T.L.; van Hulst, L.T.; Laar, M.A. van der; van Riel, P.L.; Albada-Kuipers, G.A. van
2011	Thematic stream: inflammatory arthritis	Vermeer, M.; Kuper, I.H.; Hoekstra, M.; Haagsma, C.J.; Posthumus, M.D.; Brus, H.L.; Riel, P.L. van; Laar, M.A. van der
2011	Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry	Arts, E.E.A.; Jansen, T.L.Th.A.; Broeder, A. den; Vonkeman, H.E.; Dutmer, E.; Laar, M.A. van der; van Riel, P.L.; Fransen, J.
2011	Tailored treatment: it's not what you think it is. Comment on the article by van Koulil et al.	Koulil, S. van; Evers, A.W.M.; Kraaimaat, F.W.; Riel, P.L.C.M. van; Lankveld, W.G.J.M. van
2011	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010	Furst, D.E.; Keystone, E.C.; Braun, J.; Breedveld, F.C.; Burmester, G.R.; Benedetti, F. De; Dorner, T.; Emery, P.; Fleischmann, R.; Gibofsky, A.; Kalden, J.R.; Kavanaugh, A.; Kirkham, B.; Mease, P.; Sieper, J.; Singer, N.G.; Smolen, J.S.; Riel, P.L. van; Weisman, M.H.; Winthrop, K.
2011	Achieving tight control in rheumatoid arthritis	Hulst, L.T.C. van; Hulscher, M.E.J.L.; Riel, P.L.C.M. van
2011	Can psychological interventions alter the physiological stress response of patients with rheumatoid arthritis?	Brouwer, S.J.M. de; Kraaimaat, F.W.; Sweep, F.C.; Donders, R.; Eijsbouts, A.M.M.; Radstake, T.R.; Riel, P.L. van; Evers, A.W.M.
2011	The effects of doxycycline on reducing symptoms in knee osteoarthritis: results from a triple-blinded randomised controlled trial	Snijders, G.F.; Ende, C.H.M. van den; van Riel, P.L.; Hoogen, F.H. Van den; Broeder, A. den
2011	Bridging the gap between aggregate data and individual patient management: a Bayesian approach	Wilt, G.J. van der; Groenewoud, H.; Riel, P.L.C.M. van
2011	Fatigue in knee and hip osteoarthritis: the role of pain and physical function	Snijders, G.F.; Ende, C.H.M. van den; Fransen, J.; Riel, P.L. van; Stukstette, M.J.; Defoort, K.C.; Arts-Sanders, M.A.; Hoogen, F.H. Van den; Broeder, A. den
2011	Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.	Radstake, T.R.D.J.; Gorlova, O.; Rueda, B.; Martin, J.E.; Alizadeh, B.Z.; Palomino-Morales, R.; Coenen, M.J.H.; Vonk, M.C.; Voskuyl, A.E.; Schuerwegh, A.J.; Broen, J.C.; Riel, P.L.C.M. van; Slot, R. van 't; Italiaander, A.; Ophoff, R.A.; Riemekasten, G.; Hunzelmann, N.; Simeon, C.P.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; Gonzalez-Escribano, M.F.; Airo, P.; Laar, J. van; Herrick, A.; Worthington, J.; Hesselstrand, R.; Smith, V.; Keyser, F. de; Houssiau, F.; Chee, M.M.; Madhok, R.; Shiels, P.; Westhovens, R.; Kreuter, A.; Kiener, H.; Baere, E. de; Witte, T.J.M. de; Padykov, L.; Klareskog, L.; Beretta, L.; Scorza, R.; Lie, B.A.; Hoffmann-Vold, A.M.; Carreira, P.; Varga, J.; Hinchcliff, M.; Gregersen, P.K.; Lee, A.T.; Ying, J.; Han, Y.; Weng, S.F.; Amos, C.I.; Wigley, F.M.; Hummers, L.; Nelson, J.L.; Agarwal, S.K.; Assassi, S.; Gourh, P.; Tan, F.K.; Koeleman, B.P.; Arnett, F.C.; Martin, J.; Mayes, M.D.
2011	The functional polymorphism 844 A>G in FcalphaRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility	Broen, J.C.; Coenen, M.J.H.; Rueda, B.; Witte, T.J.M. de; Padyukov, L.; Klareskog, L.; Hesselstrand, R.; Wuttge, D.M.; Simeon, C.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; Pros, A.; Hunzelman, N.; Riemekasten, G.; Kreuter, A.; Vonk, M.C.; Scorza, R.; Beretta, L.; Airo, P.; Riel, P.L. van; Kimberly, R.; Martin, J.; Edberg, J.; Radstake, T.R.D.J.
2011	Rituximab treatment in patients with refractory inflammatory myopathies	Mahler, E.A.; Blom, M.; Voermans, N.C.; Engelen, B.G. van; Riel, P.L. van; Vonk, M.C.
2011	Evidence-based tailored conservative treatment of knee and hip osteoarthritis: between knowing and doing	Snijders, G.F.; Broeder, A. den; Riel, P.L. van; Straten, V.H.; Man, F.H. de; Hoogen, F.H. Van den; Ende, C.H.M. van den
2011	Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region	Martin, J.E.; Alizadeh, B.Z.; Gonzalez-Gay, M.A.; Balsa, A.; Pascual-Salcedo, D.; Gonzalez-Escribano, M.F.; Rodriguez-Rodriguez, L.; Fernandez-Gutierrez, B.; Raya, E.; Coenen, M.J.H.; Riel, P.L.C.M. van; Radstake, T.R.D.J.; Kvien, T.K.; Viken, M.K.; Lie, B.A.; Koeleman, B.P.; Martin, J.
2011	Induction of nocebo and placebo effects on itch and pain by verbal suggestions	Laarhoven, A.I.M. van; Vogelaar, M.L.; Wilder-Smith, O.H.G.; Riel, P.L.C.M. van; Kerkhof, P.C.M. van de; Kraaimaat, F.W.; Evers, A.W.M.
2011	Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment	Hulst, L.T. van; Kievit, W.; Bommel, R. van; Riel, P.L. van; Fraenkel, L.
2011	Effectiveness of a Third Tumor Necrosis Factor-alpha-blocking Agent Compared with Rituximab After Failure of 2 TNF-blocking Agents in Rheumatoid Arthritis	Blom, M.; Kievit, W.; Donders, A.R.T.; Broeder, A. den; Straten, V.H.; Kuper, I.; Visser, H.; Jansen, T.L.Th.A.; Brus, H.L.; Branten, A.J.W.; Laar, M.A. van der; Riel, P.L. van
2011	Tailored cognitive-behavioural therapy and exercise training improves the physical fitness of patients with fibromyalgia	Spillekom-van Koulil, S.; Lankveld, W.G.J.M. van; Kraaimaat, F.W.; Helmond, T. van; Vedder, A.; Hoorn, H. van; Donders, A.R.T.; Wirken, L.; Cats, H.; Riel, P.L.C.M. van; Evers, A.W.M.
2011	Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis	Wenink, M.H.; Santegoets, K.C.M.; Butcher, J.; Bon, L. van; Lamers-Karnebeek, F.B.G.; Berg, W.B. van den; Riel, P.L. van; McInnes, I.B.; Radstake, T.R.D.J.
2011	Are patients' judgments of health status really different from the general population?	Krabbe, P.F.M.; Tromp, N.; Ruers, T.J.M.; Riel, P.L. van
2011	Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study	Bemt, B.J.F van den; Broeder, A. den; Wolbink, G.J.; Hekster, Y.A.; Riel, P.L. van; Benraad, B.; Hoogen, F.H. Van den
2011	Treatment strategies aiming at remission in early rheumatoid arthritis patients: starting with methotrexate monotherapy is cost-effective	Schipper, L.G.; Kievit, W.; Broeder, A. den; Laar, M.A. van der; Adang, E.M.M.; Fransen, J.; Riel, P.L.C.M. van
2011	Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis	Bemt, B.J.F van den; Broeder, A. den; Hoogen, F.H. Van den; Benraad, B.; Hekster, Y.A.; van Riel, P.L.; Lankveld, W.G.J.M. van
2011	Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice	Moots, R.J.; Haraoui, B.; Matucci-Cerinic, M.; Riel, P.L. van; Kekow, J.; Schaeverbeke, T.; Davis, A.; Tedeschi, M.A.; Freundlich, B.; Chang, D.J.; Singh, A.
2011	Validating the 28-tender joint count using item response theory.	Siemons, L.; Klooster, P.M. ten; Taal, E.; Kuper, I.H.; Riel, P.L.C.M. van; Laar, M.A. van der; Glas, C.A.
2011	The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype	Dawidowicz, K.; Allanore, Y.; Guedj, M.; Pierlot, C.; Bombardieri, S.; Balsa, A.; Westhovens, R.; Barrera, P.; Alves, H.; Teixeira, V.H.; Petit-Teixeira, E.; Putte, L.B.A. van de; Riel, P.L.C.M. van; Prum, B.; Bardin, T.; Meyer, O.; Cornelis, F.; Dieude, P.
2011	Cognitive-behavioral mechanisms in a pain-avoidance and a pain-persistence treatment for high-risk fibromyalgia patients	Koulil, S. van; Kraaimaat, F.W.; Lankveld, W.G.J.M. van; Helmond, T. van; Vedder, A.; Hoorn, H. van; Donders, A.R.T.; Thieme, K.; Cats, H.; Riel, P.L. van; Evers, A.W.M.
2011	Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study	Vermeer, M.; Kuper, H.H.; Hoekstra, M.; Haagsma, C.J.; Posthumus, M.D.; Brus, H.L.; van Riel, P.L.; Laar, M.A. van der
2011	No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data	Garcia-Bermudez, M.; Lopez-Mejias, R.; Rodriguez-Rodriguez, L.; Fernandez-Gutierrez, B.; Garcia, A.; Raya, E.; Ortiz, A.M.; Coenen, M.J.H.; Riel, P.L. van; Radstake, T.R.D.J.; Gonzalez-Gay, M.A.; Martin, J.
2011	Psychophysiological responses to stress after stress management training in patients with rheumatoid arthritis.	Brouwer, S.J.M. de; Kraaimaat, F.W.; Sweep, F.C.; Donders, A.R.T.; Eijsbouts, A.; Koulil, S. van; Riel, P.L.C.M. van; Evers, A.W.M.
2011	Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade	Heinhuis, B.; Koenders, M.M.J.F.; Riel, P.L.C.M. van; Loo, F.A.J. van de; Dinarello, C.A.; Netea, M.G.; Berg, W.B. van den; Joosten, L.A.B.
2011	Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register	Kievit, W.; Fransen, J.; Adang, E.M.M.; Broeder, A. den; Bernelot Moens, H.J.; Visser, H.; Laar, M.A. van der; Riel, P.L. van
2011	Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci	Zhernakova, A.; Stahl, E.A.; Trynka, G.; Raychaudhuri, S.; Festen, E.A.; Franke, L.; Westra, H.J.; Fehrmann, R.S.; Kurreeman, F.A.; Thomson, B.; Gupta, N.; Romanos, J.; McManus, R.; Ryan, A.W.; Turner, G.; Brouwer, E.; Posthumus, M.D.; Remmers, E.F.; Tucci, F.; Toes, R.; Grandone, E.; Mazzilli, M.C.; Rybak, A.; Cukrowska, B.; Coenen, M.J.H.; Radstake, T.R.D.J.; Riel, P.L. van; Li, Y.; Bakker, P.I. de; Gregersen, P.K.; Worthington, J.; Siminovitch, K.A.; Klareskog, L.; Huizinga, T.W.J.; Wijmenga, C.; Plenge, R.M.
2011	Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries	Chatzidionysiou, K.; Lie, E.; Nasonov, E.; Lukina, G.; Hetland, M.L.; Tarp, U.; Gabay, C.; Riel, P.L. van; Nordstrom, D.C.; Gomez-Reino, J.; Pavelka, K.; Tomsic, M.; Kvien, T.K.; Vollenhoven, R.F. van
2011	Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia	Santen, S. van; Dongen-Lases, E.C. van; Vegt, F. de; Laarakkers, C.M.; Riel, P.L. van; Ede, A.E. van; Swinkels, D.W.
2011	The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples	Rodriguez-Rodriguez, L.; Taib, W.R.; Topless, R.; Steer, S.; Gonzalez-Escribano, M.F.; Balsa, A.; Pascual-Salcedo, D.; Gonzalez-Gay, M.A.; Raya, E.; Fernandez-Gutierrez, B.; Gonzalez-Alvaro, I.; Bottini, N.; Witte, T.J.M. de; Viken, M.K.; Coenen, M.J.H.; Riel, P.L. van; Franke, B.; Heijer, M. den; Radstake, T.R.D.J.; Wordsworth, P.; Lie, B.A.; Merriman, T.R.; Martin, J.
2011	Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy	Gorlova, O.; Martin, J.E.; Rueda, B.; Koeleman, B.P.; Ying, J.; Teruel, M.; Diaz-Gallo, L.M.; Broen, J.C.; Vonk, M.C.; Simeon, C.P.; Alizadeh, B.Z.; Coenen, M.J.H.; Voskuyl, A.E.; Schuerwegh, A.J.; Riel, P.L. van; Vanthuyne, M.; Slot, R. van 't; Italiaander, A.; Ophoff, R.A.; Hunzelmann, N.; Fonollosa, V.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; Garcia-Hernandez, F.J.; Gonzalez-Escribano, M.F.; Airo, P.; Laar, J. van; Worthington, J.; Hesselstrand, R.; Smith, V.; Keyser, F. de; Houssiau, F.; Chee, M.M.; Madhok, R.; Shiels, P.G.; Westhovens, R.; Kreuter, A.; Baere, E. de; Witte, T.J.M. de; Padyukov, L.; Nordin, A.; Scorza, R.; Lunardi, C.; Lie, B.A.; Hoffmann-Vold, A.M.; Palm, O.; Garcia de la Pena, P.; Carreira, P.; Varga, J.; Hinchcliff, M.; Lee, A.T.; Gourh, P.; Amos, C.I.; Wigley, F.M.; Hummers, L.K.; Hummers, J.; Nelson, J.L.; Riemekasten, G.; Herrick, A.; Beretta, L.; Fonseca, C.; Denton, C.P.; Gregersen, P.K.; Agarwal, S.; Assassi, S.; Tan, F.K.; Arnett, F.C.; Radstake, T.R.D.J.; Mayes, M.D.; Martin, J.
2010	E-health behandelingen bij chronische lichamelijke aandoeningen: het patiëntenperspectief.	Evers, A.W.M.; Burik, A. van; Goor, S.S. van de; Hoeve, D.; Fransen, J.; Creemers, M.C.W.; Riel, P.L.C.M. van
2010	Unregulated prescribing of anti-tumour necrosis factor agents does not mean inappropriate prescribing.	Ng, C.T.; Radovits, B.J.; Kievit, W.; Fransen, J.; Riel, P.L.C.M. van; Fitzgerald, O.; Veale, D.J.; Bresnihan, B.
2010	Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care.	Janssens, H.J.E.M.; Janssen, M.; Lisdonk, E.H. van de; Fransen, J.; Riel, P.L.C.M. van; Weel, C. van
2010	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.	Furst, D.E.; Keystone, E.C.; Fleischmann, R.; Mease, P.; Breedveld, F.C.; Smolen, J.S.; Kalden, J.R.; Braun, J.; Bresnihan, B.; Burmester, G.R.; Benedetti, F. De; Dorner, T.; Emery, P.; Gibofsky, A.; Kavanaugh, A.; Kirkham, B.; Schiff, M.H.; Sieper, J.; Singer, N.; Riel, P.L.C.M. van; Weinblatt, M.E.; Weisman, M.H.; Winthrop, K.
2010	Multiplex screening of 22 single-nucleotide polymorphisms in 7 Toll-like receptors: an association study in rheumatoid arthritis.	Enevold, C.; Radstake, T.R.D.J.; Coenen, M.J.H.; Fransen, J.; Toonen, E.J.M.; Bendtzen, K.; Riel, P.L.C.M. van
2010	Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data.	Beretta, L.; Santaniello, A.; Riel, P.L.C.M. van; Coenen, M.J.H.; Scorza, R.
2010	Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data.	Dougados, M.; Wells, G.; Schmidely, N.; Bars, M. Le; Riel, P.L.C.M. van; Aletaha, D.; Schiff, M.; Smolen, J.
2010	Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses.	Brouwer, S.J.M. de; Kraaimaat, F.W.; Sweep, F.C.; Creemers, M.C.W.; Radstake, T.R.D.J.; Laarhoven, A.I.M. van; Riel, P.L.C.M. van; Evers, A.W.M.
2010	Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis.	Hoogmoed, D. van; Fransen, J.; Bleijenberg, G.; Riel, P.L.C.M. van

1 2 3 4 5 6 next